Estimation of Programed Death Ligand_1 Concentrations in Serum and Tissue Among Iraqi Breast Diseases
Background:A programed death ligand L1 is the particular PD-1 ligand that is primarily found in lymphoid, epithelial, and myeloid cells. In order to activate the PD-1/PD-L1 pathway, which suppresses the production of cytokines and controls immune function, PD-1 must bind to PD-L1. Objectives:Estimat...
Saved in:
| Main Authors: | Noor AL_huda Razakh Huadi, Frial G. Abd, Liqaa Y. Mohsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-09-01
|
| Series: | Medical Journal of Babylon |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/MJBL.MJBL_1727_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of quality of life and periodontal health with an eight-unit maxillary fixed retainer through a prospective clinical trial
by: Mohamed H. Abbas, et al.
Published: (2025-02-01) -
Polarization demultiplexing by ICA in a polarization multiplexing system with both PMD and PDL
by: Ling ZHAO, et al.
Published: (2013-10-01) -
Simultaneous effect of physical activity and anti-PDL1 injection on tumor weight and life span of mice with breast cancer
by: Amir Hossein Ahmadi Hekmatikar, et al.
Published: (2024-06-01) -
Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review
by: Muhammad Taqi, et al.
Published: (2024-12-01) -
Inactive-enriched machine-learning models exploiting patent data improve structure-based virtual screening for PDL1 dimerizers
by: Pablo Gómez-Sacristán, et al.
Published: (2025-01-01)